The NF-κB cascade is important in Bcl-x(L) expression and for the anti- apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 1743-1754

  Khoshnan, A ^a   Tindell, C ^a   Laux, I ^a   Bae, D ^a   Bennett, B ^a   Nel, A E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL PROTECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; T LYMPHOCYTE; UNINDEXED SEQUENCE;

EID: 0034663779     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.1743     Document Type: Article

References (62)

1. Mature T lymphocytes apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
2. Stress-induced Fas ligand expression in T cells is mediated thorough a MEK kinase 1-regulated response element in the Fas ligand promoter
3. Signal transduction by lymphocyte antigen receptors
4. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: Proof of cross-talk with the IκB kinase cascade
5. + T cells contain heterogeneous IκB kinase complexes: Role in activation of the IL-2 promoter
6. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: A mechanism for NF-κB activation
7. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli
8. CD28 mediates transcriptional up-regulation of the interleukin-2 (IL- 2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites
9. + mature thymocytes
10. Regulation of interleukin-2 gene enhancer activity by the T-cell accessory molecule CD28
11. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
12. Upstream-downstream: CD28 cosignaling pathways and T cell function
13. Molecular regulation of interleukin-2 expression by CD28 co- stimulation and anergy
14. NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type
15. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras
16. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase-8 activation
17. NF-κB is activated and promotes cell death in focal cerebral ischemia
18. NF-κB to the rescue: RELs, apoptosis and cellular transformation
19. Inhibition of TNF-induced apoptosis by NF-κB
20. c-Rel is essential for B lymphocyte survival and cell cycle progression
21. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
22. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
23. NF-κB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes
24. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-x(L)
25. CD28 co-stimulation prevents cell death during primary T cell activation
26. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax
27. NF-κB-mediated up-regulation of Bcl-X and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
28. + T cells in the absence of exogenous feeder cells
29. Graded transcriptional response to different concentrations of a single transactivator
30. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
31. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
32. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene
33. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in Jurkat T cells: Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation
34. Tumor necrosis factor induces bcl-2 and bcl-x expression through NF- κB activation in primary hippocampal neurons
35. IEX-IL, an apoptosis inhibitor involved in NF-κB-mediated cell survival
36. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
37. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
38. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas- induced protease activation
39. TNF receptor-2-triggered apoptosis is associated with the down- regulation of Bcl-x(L) on activated T cells and can be prevented by CD28 costimulation
40. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-B
41. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation
42. Dithiocarbamate as potent inhibitors of nuclear factor κB activation in intact cells
43. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
44. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells
45. Bcl-x(L) regulates the membrane potential and volume homeostasis of mitochondria
46. The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins
47. Inhibition of NF-κB activity in human T lymphocytes induces caspase- dependent apoptosis without detectable activation of caspase-1 and -3
48. CTLA-4 ligation suppresses CD28-induced NF-κB and AP-1 activity in mouse T cell blasts
49. Role of the CTLA-4 receptor in T cell activation and immunity: Physiologic function of the CTLA-4 receptor
50. Bcl-x(L) prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange
51. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
52. Severe liver degeneration in mice lacking the IκB kinase 2 gene
53. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
54. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis
55. Aspirin and salicylate induce apoptosis and activation of caspase in B-cell chronic lymphocytic leukemia cells
56. Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines
57. Modulation of cell death by Bcl-x(L) through caspase interaction
58. Bcl-x(L) interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
59. Bcl-x(L) regulates apoptosis by heterodimerization-dependent and - independent mechanisms
60. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
61. The human T-cell leukemia virus type-1 Tax protein regulates the activity of the IκB kinase complex